Janus kinase-2 signaling mediates apoptosis in rat cardiomyocytes

Eduardo Mascareno1, Daniel L Beckles, M A Q Siddiqui

  • 1Center for Cardiovascular and Muscle Research, Department of Anatomy and Cell Biology, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, N.Y. 11203, USA.

Vascular Pharmacology
|November 5, 2005
PubMed

Insights

Janus kinase 2 (Jak2) signaling mediates cardiac myocyte apoptosis induced by Angiotensin II and hypoxia/reoxygenation. Inhibiting Jak2 with Tyrphostin AG490 blocked these apoptotic pathways, suggesting Jak2 as a therapeutic target.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cell Death Signaling

Background:

  • The renin-angiotensin system (RAS) plays a crucial role in cardiovascular regulation.
  • Angiotensin II (Ang II) and oxidative stress contribute to cardiac myocyte apoptosis.
  • Janus kinase 2 (Jak2) is implicated in signaling pathways relevant to cardiovascular disease.

Purpose of the Study:

  • To investigate the role of Jak2 activation in mediating apoptosis of cardiac myocytes induced by Angiotensin II (Ang II) and hypoxia/reoxygenation.
  • To determine if Jak2 acts as a central mediator for signals leading to enhanced cardiomyocyte susceptibility to cell death.
  • To explore the impact of Jak2 inhibition on pro-apoptotic and anti-apoptotic signaling pathways in cardiomyocytes.

Main Methods:

  • Adult rat cardiomyocytes were treated with Ang II or subjected to hypoxia/reoxygenation.
  • Western blotting was used to assess protein phosphorylation and expression (Jak2, Stat1, JNK, Bax, S6 ribosomal protein, HSP27).
  • Caspase-1 and caspase-3 activities were measured.
  • Pharmacological inhibitors (Tyrphostin AG490 for Jak2, Losartan for AT1 receptor) were employed.

Main Results:

  • Ang II treatment induced cardiomyocyte apoptosis, increased pro-apoptotic markers (phosphorylated Jak2, Stat1, JNK, Bax), and activated caspases.
  • Hypoxia/reoxygenation also triggered apoptosis dependent on Jak2 activation.
  • The Jak2 inhibitor Tyrphostin AG490 significantly reduced apoptosis and downstream signaling in both models.
  • Losartan also attenuated the apoptotic response to hypoxia/reoxygenation.
  • Cardioprotective pathways involving S6 ribosomal protein and HSP27 were concurrently activated.

Conclusions:

  • Jak2 signaling is a critical mediator of Angiotensin II- and hypoxia/reoxygenation-induced apoptosis in cardiac myocytes.
  • Pharmacological inhibition of Jak2 effectively blocks these apoptotic pathways, highlighting its potential as a therapeutic target.
  • While Jak2 activation promotes apoptosis, there is a concurrent activation of cytoprotective signaling pathways that may serve as a negative feedback mechanism.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...